CLINICAL TRIALS PROFILE FOR LEVULAN
✉ Email this page to a colleague
All Clinical Trials for levulan
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00524485 ↗ | Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis | Terminated | National Cancer Institute (NCI) | N/A | 2005-05-01 | RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis. |
| NCT00524485 ↗ | Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis | Terminated | Roswell Park Cancer Institute | N/A | 2005-05-01 | RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis. |
| NCT00706433 ↗ | Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne | Completed | DUSA Pharmaceuticals, Inc. | Phase 2 | 2007-03-01 | The purpose of this study is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy treatments with aminolevulinic acid (ALA-PDT) and vehicle (VEH-PDT) in subjects with moderate to severe facial acne vulgaris. |
| NCT00865878 ↗ | ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients | Terminated | DUSA Pharmaceuticals, Inc. | Phase 2 | 2009-05-01 | The purpose of this study is to determine and compare the safety and efficacy of broad area photodynamic therapy with aminolevulinic acid (ALA-PDT) versus vehicle PDT (VEH-PDT) in the treatment of actinic keratoses (AK) and reduction of new non-melanoma skin cancer (NMSC) of the scalp or both forearms in solid organ transplant recipient subjects receiving chronic immunosuppressive therapy. |
| NCT01053000 ↗ | Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses | Completed | Stewart, Roger H., M.D., P.A. | N/A | 2010-01-01 | To determine and compare the safety and efficacy of broad area photodynamic therapy with aminolevulinic acid (ALA-PDT) following topical retinoid pre-treatment vs ALA-PDT with occlusion only (no pretreatment) in subjects with dorsal hand/forearm actinic keratoses, with an incubation time of 60 minutes, using blue light. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for levulan
Condition Name
Clinical Trial Locations for levulan
Trials by Country
Clinical Trial Progress for levulan
Clinical Trial Phase
Clinical Trial Sponsors for levulan
Sponsor Name
